Indiana University School of Medicine
Clinical and translational research collaboration in multiple myeloma and plasma cell dyscrasias, with emphasis on novel immunotherapies, bispecific antibodies, cellular therapy, myeloma biology, the tumor-bone and bone marrow microenvironment, and development of therapeutic strategies that expand patient access to advanced myeloma treatments.
Qualification
MD; American Board of Internal Medicine; American Board of Medical Oncology; American Board of Hematology
Title and Affiliation
Professor of Clinical Medicine, Division of Hematology and Oncology, Indiana University School of Medicine; Gladstein Professor of Cancer Research; Program Director, Plasma Cell Dyscrasia Program; Staff Physician, Richard L. Roudebush Veterans Administration Medical Center
Brief Description of Collaboration
- Clinical and translational research collaboration in multiple myeloma and plasma cell dyscrasias, with emphasis on novel immunotherapies, bispecific antibodies, cellular therapy, myeloma biology, the tumor-bone and bone marrow microenvironment, and development of therapeutic strategies that expand patient access to advanced myeloma treatments.
Email: [email protected]
Link: https://medicine.iu.edu/faculty/5033/suvannasankha-attaya?utm_source=chatgpt.com
